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Receptor tyrosine phosphatases guide vertebrate motor axons
during development
Abstract
Receptor-type protein tyrosine phosphatases (RPTPs) are required for appropriate growth of axons
during nervous system development in Drosophila. In the vertebrate, type IIa RPTPs [protein tyrosine
phosphatase (PTP)-delta, PTP-sigma, and LAR (leukocyte common-antigen-related)] and the type III
RPTP, PTP receptor type O (PTPRO), have been implicated in the regulation of axon growth, but their
roles in developmental axon guidance are unclear. PTPRO, PTP-delta, and PTP-sigma are each
expressed in chick motor neurons during the period of axonogenesis. To examine potential roles of
RPTPs in axon growth and guidance in vivo, we used double-stranded RNA (dsRNA) interference
combined with in ovo electroporation to knock down RPTP expression levels in the embryonic chick
lumbar spinal cord. Although most branches of the developing limb nerves appeared grossly normal, a
dorsal nerve identified as the anterior iliotibialis was clearly affected by dsRNA knock-down of RPTPs.
In experimental embryos treated with dsRNA targeting PTP-delta, PTP-sigma, or PTPRO, this nerve
showed abnormal fasciculation, was reduced in size, or was missing entirely; interference with PTPRO
produced the most severe phenotypes. Control embryos electroporated with vehicle, or with dsRNA
targeting choline acetyltransferase or axonin-1, did not exhibit this phenotype. Surprisingly, embryos
electroporated with dsRNA targeting PTP-delta together with PTPRO, or all three RPTPs combined,
had less severe phenotypes than embryos treated with PTPRO alone. This result suggests that
competition between type IIa and type III RPTPs can regulate motor axon outgrowth, consistent with
findings in Drosophila. Our results indicate that RPTPs, and especially PTPRO, are required for axon
growth and guidance in the developing vertebrate limb.
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Receptor-type protein tyrosine phosphatases (RPTPs) are required for appropriate growth of axons during nervous systemdevelopment
in Drosophila. In the vertebrate, type IIa RPTPs [protein tyrosine phosphatase (PTP)-, PTP-, and LAR (leukocyte common-antigen-
related)] and the type III RPTP, PTP receptor type O (PTPRO), have been implicated in the regulation of axon growth, but their roles in
developmental axon guidance are unclear. PTPRO, PTP-, and PTP- are each expressed in chick motor neurons during the period of
axonogenesis. To examine potential roles of RPTPs in axon growth and guidance in vivo, we used double-stranded RNA (dsRNA)
interference combined with in ovo electroporation to knock down RPTP expression levels in the embryonic chick lumbar spinal cord.
Althoughmost branches of the developing limb nerves appeared grossly normal, a dorsal nerve identified as the anterior iliotibialis was
clearly affected by dsRNA knock-down of RPTPs. In experimental embryos treated with dsRNA targeting PTP-, PTP-, or PTPRO, this
nerve showed abnormal fasciculation, was reduced in size, or was missing entirely; interference with PTPRO produced the most severe
phenotypes. Control embryos electroporatedwith vehicle, or with dsRNA targeting choline acetyltransferase or axonin-1, did not exhibit
this phenotype. Surprisingly, embryos electroporated with dsRNA targeting PTP- together with PTPRO, or all three RPTPs combined,
had less severe phenotypes than embryos treated with PTPRO alone. This result suggests that competition between type IIa and type III
RPTPs can regulate motor axon outgrowth, consistent with findings in Drosophila. Our results indicate that RPTPs, and especially
PTPRO, are required for axon growth and guidance in the developing vertebrate limb.
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Introduction
Receptor protein tyrosine phosphatases (RPTPs) are transmem-
brane proteins implicated in the regulation of axon growth and
guidance (Bixby, 2000; Johnson and Van Vactor, 2003). In par-
ticular, genetic evidence implicates type IIa and type III RPTPs in
pathway selection by photoreceptors, CNS axons, and motor
neurons in Drosophila (Van Vactor et al., 1998; Newsome et al.,
2000; Clandinin et al., 2001; Maurel-Zaffran et al., 2001; Schin-
delholz et al., 2001; Sun et al., 2001). The low penetrance of
defects in RPTP null mutants, and similarities in phenotypes be-
tween null mutants of different RPTPs, suggest redundancy in
RPTP function during axonogenesis. However, examination of
multiple mutants indicates both cooperation and competition
among RPTPs in guiding axons (Desai et al., 1997; Schindelholz
et al., 2001).
Evidence of RPTP function in vertebrate axon pathfinding is
less clear. In vitro evidence links the vertebrate type IIa RPTPs
leukocyte common-antigen-related (LAR), protein tyrosine
phosphatase (PTP)-, and PTP- to axon growth regulation
(Ledig et al., 1999b;Wang and Bixby, 1999; Q. L. Sun et al., 2000;
Yang et al., 2003), and similar evidence has been obtained for the
type III RPTP, PTP receptor type O (PTPRO) (Stepanek et al.,
2001). Experiments using putative dominant-negative mutants
of PTP- andPTP- suggest involvement of theseRPTPs in path-
finding in vivo (Johnson et al., 2001; Rashid-Doubell et al., 2002).
LAR, PTP-, and PTP-mutant mice have nervous system phe-
notypes, some of whichmay be related to axon growth (Yeo et al.,
1997; Elchebly et al., 1999; Wallace et al., 1999; Uetani et al.,
2000). Finally, LAR and PTP- null mutants exhibit aberrant
peripheral nerve regeneration (Xie et al., 2001; McLean et al.,
2002; Thompson et al., 2003; Van der Zee et al., 2003). Direct
loss-of-function experiments linking these RPTPs to develop-
mental axon guidance have not been reported.
The routes taken by embryonic motor axons to their targets
are relatively well understood. In the chick spinal cord, axons
from different motor pools are intermingled, because they grow
toward a “choice point” at the base of the limb; there, axons
segregate and extend dorsally or ventrally (Landmesser, 1978b;
Lance-Jones and Landmesser, 1981). In the limb, axons diverge
again to grow to their proper target muscles (Lance-Jones and
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Landmesser, 1981; Tosney and Landmesser, 1985). Type IIa and
type III RPTPs are involved in decision making at motor neuron
choice points in Drosophila, and these functions may be con-
served. Because several such RPTPs are expressed in embryonic
chickmotor neurons, these neurons should be a useful system for
examining the roles of RPTPs in vertebrate axon guidance.
In the chick, RNA interference (RNAi) can be combined with
in ovo electroporation to knock down expression of guidance
proteins in the developing spinal cord (Pekarik et al., 2003). We
used this methodology to perform loss-of-function experiments
for PTP-, PTP-, and PTPRO in developing spinal motor neu-
rons. Our studies provide the first evidence for the involvement
of a vertebrate type III RPTP in axon growth in vivo, and support
the idea of cooperation and competition among vertebrate
RPTPs in regulation of motor axon pathfinding.
Materials andMethods
Materials. Fertilized White Leghorn chicken eggs were purchased from
SPAFAS (Norwich, CT) and incubated in a humidified incubator at 38°C
until the desired stage of development. All of the chemicals were pur-
chased from Sigma (St. Louis, MO) unless stated otherwise.
In situ hybridization. Plasmids containing cDNA for base pairs 382–
1004 of chick (c)PTPRO (accession number U65891), base pairs 1093–
1489 of cPTP- (accession number L32780), and a portion of cPTP-
that aligns to base pairs 877–1478 of human PTP- (accession number
L38929) were linearized and used as templates for transcription of sense
and antisense digoxygenin-labeled riboprobes using the recommended
procedure (Roche, Mannheim, Germany). Embryos were dissected at
embryonic day 5.5 (E5.5), fixed in 4% paraformaldehyde overnight, cryo-
protected in 30% sucrose overnight, and frozen in OCT (Tissue Tek; Fisher
Scientific, Pittsburgh, PA) for cryosectioning. Ten-micrometer-thick sec-
tions were allowed to dry and processed for in situ hybridization following a
standard protocol (Schaeren-Wiemers and Gerfin-Moser, 1993). Sections
were hybridized overnight with 600 ng/ml riboprobe at 56°C.
Production of double-stranded RNA. Sense and antisense RNAs were
produced from plasmids encoding portions of cPTP- (base pairs 1093–
1489), cPTP- (aligns to base pairs 877–1478 of humanPTP-), cPTPRO
(base pairs 1458–2334), and cChAT (base pairs 1344–1665; accession
number AY044155). After linearization with the appropriate restriction
endonucleases, RNA was transcribed using the SP6 and T7 MegaScript
kits from Ambion (Austin, TX). RNA was cleaned, analyzed, and an-
nealed as described previously (Pekarik et al., 2003).
In ovo RNA interference. Double-stranded RNA (dsRNA) injection
and electroporation were performed as described previously (Pekarik et
al., 2003). Embryos were injected at E3 to E3.5 [Hamburger and Hamil-
ton stages (HH) 18–20] and dissected 48–60 h later (HH25–27). dsRNA
for combinatorial RNA interference (RNAi) was injected at a final con-
centration of 500 ng/l for each RNA. This gave molarities of 1.7 M for
PTP-, 1.1 M for PTP-, 0.8 M for PTPRO, and 2.0 M for choline
acetyltransferase (ChAT).
Western blotting. Embryos were dissected 48 h postelectroporation in
cold PBS–glucose. The lumbosacral portions of 10–15 spinal cords were
split into right and left sides and lysed in 1% Igepal CA-630, 5mMEDTA,
100 g/ml PMSF, 1 mg/ml leupeptin, 1 mg/ml aprotinin, and 1 mg/ml
pepstatin A in TBS (25 mM Tris, 150 mM NaCl, pH 7.4) for 30 min.
Undissolved pellets were cleared by centrifugation (12,000 g; 30 min),
and 50g of supernatant proteinwas separated on SDS-PAGE and trans-
ferred to nitrocellulose as described previously (Bixby and Jhabvala,
1990). Primary antibodies were rabbit anti-cPTPRO (Ledig et al., 1999a)
at 1:2500, or rabbit anti-cPTP- (Stoker et al., 1995) at 1:5000. Secondary
antibody was Alexa Fluor 680 goat anti-rabbit IgG (Molecular Probes,
Eugene, OR). After rinsing, blots were incubated with anti-chick L1 cell
adhesionmolecule (L1CAM) (Lemmon andMcLoon, 1986), followed by
infrared dye 800-conjugated anti-mouse IgG (Rockland, Gilbertsville,
PA). Bound antibody was visualized, and band intensity was quantified
using the LI-COR (Lincoln, NE) Odyssey Infrared Imaging System.
Whole-mount embryo staining. Embryos were dissected and fixed in
4% paraformaldehyde overnight. After rinsing in PBS, embryos were
incubated in 1% Triton X-100 for 1 h, followed by 20 mM lysine in 0.1 M
sodium phosphate for 1 h, followed by blocking in 10% goat serum in
PBS for 4 h. Embryos were incubated in anti-neurofilament-M antibody
(RMO270; Zymed, San Francisco, CA) diluted 1:1500 in blocking solu-
tion for 48 h at 4°C. Embryos were rinsed overnight in PBS, and then
incubated in cyanine 3 (Jackson ImmunoResearch, West Grove, PA) or
Alexa Fluor 594 goat anti-mouse IgG (Molecular Probes) diluted 1:2000,
for 16 h at 4°C.
Phenotype quantification. Embryos were categorized as unaffected or
affected by experimenters blinded to treatment group. An initial sub-
group, containing embryos from all single-treatment, PBS, and control
groups, were analyzed separately by three experimenters and categorized
by each based on comparison of the treated anterior iliotibialis (AITIB)
with the untreated AITIB. Embryos were categorized as affected if there
was a gross difference in morphology or nerve size between the electro-
porated and nonelectroporated sides, including missing nerves, severely
truncated nerves, or gross changes in branching/fasciculation.
For calculation of nerve area, images of neurofilament-stained nerves
were capturedwith aNikon (Melville, NY)Coolpix 990 cameramounted
on aNikonEclipse TE300microscope. An algorithmdesigned in Igor Pro
4.01 (A. R. Rosendahl, University of Miami, Miami, FL) was used to
analyze the images. Briefly, the algorithm used an adaptive thresholding
process to extract nerve pixels from background. The same images were
used for Neurolucida analysis. An experimenter traced each branch of
the nerves inNeurolucida 5.04.3 (MicroBrightField,Williston, VT). This
tracing was then used by Neuorexplorer 3.60.3 (MicroBrightField) to
calculate branch length and the number of primary branches (defined as
branching of axon bundles from the main axon fascicle) for each nerve.
For all of the quantitative measures, we calculated the ratio of the mea-
surements between treated and untreated nerve. These values were then
used to compare all of the treatment groups using nonparametric
ANOVA (Kruskal–Wallis test) followed by Dunn’s multiple compari-
sons test to compare individual treatment groups.
1,1-Dioctadecyl-3,3,3,3-tetramethylindocarbocyanine perchlorate tracing.
After dissection, embryos were stored in 4%paraformaldehyde. For retrograde
tracing, nitrocellulose membrane was soaked with a 1 mg/g dimethylform-
amide solution of 1,1-dioctadecyl-3,3,3,3-tetramethylindocarbocyanine per-
chlorate (DiI) (D-282; Molecular Probes) and allowed to dry. Small pieces of
nitrocellulose were inserted into the limb bud in the termination zone of the
AITIB.Embryoswerestoredat37°Cfor5d.Aftertracingwascomplete,embryos
were embedded in6.25%agar type IX, and250mtransverse sectionswere cut
on an oscillating tissue slicer (Electron Microscopy Sciences, Ft. Washington,
PA). Anterograde tracing was performed on 250 m sections cut in the same
way. The untreated side of the embryo wasmarked with india ink. Glass capil-
laries with a tip diameter of5mwere dipped into 5mg/mlDiI dissolved in
ethanol and placed into the ventrolateral spinal cord. After 1 h, capillaries were
removed, and the sectionswere stored in the dark at room temperature for 7 d.
Images were scanned using a Zeiss (Oberkochen, Germany) LSM510 confocal
microscope (Miami Project to Cure Paralysis), and manipulated in Adobe
Photoshop.
Islet-2 staining and design-based stereology. Embryos were dissected
and fixed at 4°C for 1.5 h. Every fifth section of 20 m cryostat sections
from the rostral lumbosacral region was processed for Islet-2 (Isl-2) im-
munohistochemistry. The Islet-2 primary antibody (51.4H9) developed
byT.M. Jessell (ColumbiaUniversity,NewYork,NY)was obtained from
the Developmental Studies Hybridoma Bank (Iowa City, IA) developed
under the auspices of the National Institute of Child Health and Human
Development and maintained by the University of Iowa (Iowa City, IA).
Sections were incubated in a 1:100 dilution of 51.4H9 at 4°C for 48 h.
After rinsing, they were incubated in a 1:1000 dilution of biotinylated
anti-mouse IgG (Vector Laboratories, Burlingame, CA). Bound anti-
body was visualized with the Vectastain Elite ABC kit (Vector Laborato-
ries) followed by a nickel-intensified DAB reaction. Stereo Investigator
5.05.04 (MicroBrightField) was used to estimate the number of Islet-2-
positive cells through the volume of the sectioned area. DAB-positive
cells were counted in the right and left ventral horns of each section using
a counting frame of 25 25 m and a scan grid size of 45 45 m. At
least 300 cells on each side were counted per embryo. From this, the
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software estimated upward of 5000 Isl-2-positive cells per side of each
embryo in the sectioned region.
PTPRO–GFP (green fluorescent protein) electroporation. PCR was used
to add a unique SalI site at base pair 3100 just 3 of the sequence encoding
the 28-aa juxtamembrane region of cPTPRO. The entire extracellular
domain, transmembrane region, and juxtamembrane region were
cloned into the pEGFP-N2 vector (Clontech, Palo Alto, CA) in-frame
with the GFP-coding sequence. This cPTPRO–GFP construct was re-
leased from the pEGFP vector and cloned into amodified pIRES plasmid
with a -actin promoter (Pekarik et al., 2003). PTPRO–GFPwas electro-
porated with dsChAT RNA or dsPTPRORNA at a final concentration of
1.5g/l. After 48 h, embryos were dissected and 100m sections of the
lumbosacral segments were cut on an oscillating tissue slicer as described
above. All of the in-focus green cells were counted in each section, and at
least 10 sections were examined per embryo.
Statistics. Statistics were done using InStat (version 2.03).
Results
RPTPs are expressed in the lateral motor column of the
embryonic chick spinal cord
The pathways taken by chick motor axons to their targets in the
hindlimb are well understood, and the motor neurons are acces-
sible for embryonic manipulation. We therefore chose to exam-
ine regulation of motor axon growth in the chick lumbosacral
spinal cord. Two type IIa RPTPs, PTP- and PTP-, and one type
III RPTP, PTPRO, are expressed during the period of axon out-
growth inmotor columns of the rodent spinal cord and the chick
brachial spinal cord (Yan et al., 1993; Sommer et al., 1997;
Chilton and Stoker, 2000; Beltran et al., 2003; Thompson et al.,
2003). To determine whether these RPTPs are also expressed in
chick lumbosacral motor neurons, we performed in situ hybrid-
ization using digoxygenin-labeled riboprobes. PTPRO mRNA
was expressed in the ventral horn, including large neurons, and in
the dorsolateral commissural neurons (Fig. 1) as well as in the
dorsal root ganglia (data not shown) of E5 chick embryos. This is
fully consistent with the pattern seen previously in the brachial
spinal cord (Chilton and Stoker, 2000). PTP- mRNA was ex-
pressed diffusely throughout the lumbar spinal cord, including
the ventral horn, and PTP- mRNA was found in the ventral
horn and in the ventricular zone (data not shown). This pattern
of mRNA expression is consistent with our hypothesis that these
three RPTPs are involved in the growth of hindlimbmotor axons
from the embryonic chick spinal cord.
Electroporation of dsRNA specifically “knocks down” protein
levels of target RPTP
To assess the roles of RPTPs in motor axon guidance, we used in
ovo electroporation combined with RNAi. Electroporation of
long dsRNAs has been shown to produce specific and reproduc-
ible decreases in expression of target proteins (Pekarik et al.,
2003). The phenotypes resulting from gene silencing by RNAi are
specific, in the sense that dsRNA targeting of known axonal guid-
ance proteins produces the same axonal pathfinding defects as
injection of cognate function-blocking antibodies, and expres-
sion levels of nontargeted proteins from the same family as the
targeted protein are not changed (Stoeckli and Landmesser, 1995;
Pekarik et al., 2003). Recently, in ovo electroporation of short
interfering RNA (siRNA) hairpins was shown to successfully
knock down neuropilin-1 in the chick spinal cord (Bron et al.,
2004). Although this methodology is advantageous in that inter-
fering RNA is continuously produced, using one long (400–800
bp) dsRNA allowed us to sidestep issues of sequence selection,
which is important because siRNAs differ in their effectiveness
(Elbashir et al., 2001; Holen et al., 2002). We produced dsRNAs
targeting the type III RPTP, PTPRO, and the type IIa RPTPs,
PTP- and PTP-. These dsRNAs were injected into the central
canal of E3.5 chick spinal cords (HH 18–20) and electroporated
into the lumbosacral region. Because the electroporation con-
fines transfection to one side of the spinal cord (Pekarik et al.,
2003) (data not shown), this side will be referred to as the
“treated” side; the other side acts as a control. After electropora-
tion, the chicks were allowed to develop for 48 h.During this time
period, motor neurons extend axons into the periphery (Ham-
burger, 1975; Oppenheim and Heaton, 1975).
We evaluated the efficacy of gene silencing by RNAi in two
ways, using PTPRO as our test protein. In an initial series of
experiments, we combined in ovo electroporation with coinjec-
tion of (1) a plasmid encoding a GFP fusion protein containing
the extracellular, transmembrane, and juxtamembrane domains
of PTPRO, and (2) dsRNA targeting either PTPRO or ChAT as a
control. This allowed us to use GFP fluorescence to evaluate any
change in transfected PTPRO expression attributable to dsRNAi.
In embryos transfected with PTPRO–GFP and dsRNA targeting
ChAT, a large number of GFP-expressing cells was always ob-
served (Fig. 2B). In contrast, many fewer GFP-positive cells were
observed after cotransfection of dsRNA targeting PTPRO (Fig.
2D). This effect was quantified by counting the number of GFP-
positive cells per section in the two conditions. On average, we
found 18.6 1.8 (mean SEM) green fluorescent cells per sec-
tion in the embryos cotransfected with ChAT dsRNA, compared
with 1.4  0.3 cells per section with PTPRO dsRNA (n  3
embryos in each group; p  0.0001). This drastic decrease in
PTPRO–GFP expressionwas apparent throughout the electropo-
rated region; there was no evidence that a subset of cells wasmore
sensitive to electroporation or RNAi.
These experiments demonstrate that our dsRNA can effec-
tively target PTPRO, but do not resolve the extent to which en-
dogenous PTPRO is affected. Because our cPTPRO antibody is
ineffective in immunohistochemistry, we examined this issue by
Western blotting. The lumbosacral spinal cords from 10–15 em-
bryos were dissected and split into left and right halves, lysed,
separated on SDS-PAGE, and probed with antibodies to RPTPs
onWestern blots. When we examined PTPRO expression in em-
bryos treatedwith dsRNA targeting PTPRO,we found the ratio of
PTPRO expression [left (or treated) side/right (or untreated)
side] to be decreased by 29% relative to this ratio in untreated
control embryos ( p  0.05) (Fig. 3). Thus, dsRNA treatment
Figure 1. PTPRO is expressed in the ventral horn of the embryonic chick spinal cord. Bright-
field (A) and phase-contrast (B) images of a cryostat section from LS 2 of E5 chick hybridized to an
antisense cPTPRO riboprobe and developed with alkaline phosphatase (blue reaction product) are
shown. PTPROmRNAwas concentrated in large cells in the lateral portionof the ventral horn, aswell
as in dorsolateral commissural neurons (arrowheads). Dorsal, Up. Scale bar, 100m.
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reduced PTPRO expression levels significantly. To evaluate the
specificity of this result, we examined the relative levels of PTP-
on the two sides of spinal cords in control embryos and embryos
treatedwith PTPROdsRNA. In this case, the expression ratio was
unchanged (5.5% increase; NS) (Fig. 3). Thus, there is a specific
decrease of the target RPTP (PTPRO) in embryos that are elec-
troporated with PTPRO dsRNA.
We also tested knock-down of a second RPTP using dsRNA
targeting PTP-; knock-down of PTP- protein was clearly seen
in Western blots (Fig. 3). Analysis of blots from three different
experiments revealed that knock-down of PTP- protein aver-
aged 25%, similar to what was seen with PTPRO dsRNA. Our
results are consistent with previous experiments demonstrating
specific knock-down of axonin-1 expression by the same proto-
col (Pekarik et al., 2003). In this study, estimated knock-down
averaged 28%, quantitatively similar to the present findings with
PTPRO and PTP-. Together, the data suggest that our RNAi
protocol specifically and effectively knocks down expression of
the target RPTP. Because our evaluation of PTPRO and PTP-
knock-down is quantitatively consistent with axonin-1 knock-
down, we expect that knock-down efficiency for PTP- is similar;
we could not test this directly becausewe lack a useful antibody to
cPTP-.
It is important to note that knock-down of PTPRO in trans-
fected neurons is underestimated by ourWestern blot data. First,
only a fraction (60%) of the cells on the treated side are trans-
fected (Pekarik et al., 2003). Thus, knock-down in transfected
cells must be at least 50%. Second, by using the entire hemicord
over the entire lumbosacral region, we are including tissue not
likely to be efficiently electroporated. Finally, PTPRO is present
in axons and growth cones (Bodden and Bixby, 1996; Stepanek et
al., 2001), and our samples will therefore contain axonal protein
from neurons outside the targeted area. It is difficult to estimate
the magnitude of the latter two effects, but our results with
PTPRO-GFP suggest that knock-down is likely to be substantially
more than 50%.
Knock-down of RPTPs produces a deficit in motor
axon pathfinding
PTP-, PTP-, and PTPRO have been shown to regulate neurite
outgrowth in vitro (Ledig et al., 1999b; Wang and Bixby, 1999;
Q. L. Sun et al., 2000; Stepanek et al., 2001), and expression of
putative dominant-negative constructs suggests that PTP- and
PTP- are involved in axon growth and guidance in the visual
system (Johnson et al., 2001; Rashid-Doubell et al., 2002). How-
ever, the involvement of these RPTPs in developmental axon
guidance has not been tested by direct loss-of-function experi-
ments in vivo. We used in ovo RNAi to examine loss-of-function
phenotypes for these RPTPs in motor axon growth.
Embryos were electroporated with dsRNA targeting PTP-,
PTP-, or PTPRO, and allowed to develop for 48–60 h (to HH
26–27). At HH 24–26, motor axons diverge from themain nerve
trunks and grow toward specificmuscles (Hamburger, 1975; Op-
Figure 2. Electroporation of dsPTPROmRNA knocks down expression of exogenous PTPRO–
GFP. Spinal cords were electroporated with a cDNA encoding a PTPRO–GFP fusion protein,
togetherwith either ChAT dsRNA (A,B) or PTPROdsRNA (C,D). After 48 h, transverse sections of
the lumbosacral spinal cord regionwere examined for GFP fluorescence. Phase-contrast images
of LS 2 sections from dsChAT embryos (A) and dsPTPRO embryos (C) are shown to the left of
fluorescent images of the same sections (B,D, respectively). Numerous cells expressingPTPRO–
GFP are visible in the embryos treated with dsChAT mRNA (B) but are barely detectable in
embryos treated with dsPTPRO (D). fp, Floorplate; vh, ventral horn. Scale bar, 100m.
Figure 3. Endogenous PTPs are selectively knocked down by electroporation with dsRNA.
A–C, Spinal cords were electroporated with PTPRO dsRNA or left untouched (Control). At E5,
lumbosacral regions of the cordswere dissected into left (treated) and right (untreated) halves,
and pooled, and levels of PTPRO and control proteins were examined by Western blot. A, B,
Representative blots of spinal cord lysates from left and right sides of experimental embryos.A,
Blot probedwith antibodies to PTPROand to L1CAM. ThePTPRObandat 180 kDa is fainter in the
treated lysate, whereas the loading control (L1CAM; 90 kDa) is slightly stronger on the treated
side. B, Blot probed with antibodies to PTP- and to L1CAM. The PTP- antibody recognizes
two bands: the full-length form, PTP-2 at 150 kDa, and PTP-1 at 90 kDa. These bands are
approximately equal in intensity between the untreated and treated sides, as is the L1CAM
band. C, Band intensity was calculated using the Odyssey system. The ratio of left:right RPTP
band intensity, normalized to L1CAM, is shown (mean SEM). Control embryos have slightly
more PTPRO and PTP- protein on the left side. Experimental embryos (dsPTPRO) show no
change in relative PTP- levels, but 21.3% less PTPRO protein on the left side. n 3 for both
control groups and dsPTPRO groups. *p 0.05, two-tailed t test comparing PTPRO groupwith
control. D, Spinal cords were electroporated with PTP- dsRNA; lumbosacral regions were
dissected and subjected toWestern blotting with antibodies to PTP- and to L1CAM.Whereas
the L1 band is approximately equal in intensity on the two sides, both PTP- bands are fainter
on the treated (left) side. The average decrease in protein on the treated side (normalized to L1)
was 25% (n 3 experiments).
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penheim and Heaton, 1975). To evaluate the growth of periph-
eral nerves, we examined neurofilament staining in whole
mounts of the lumbosacral region of the embryo. RNAi of RPTPs
did not grossly affect the major nerve branches in the hindlimb
(data not shown). However, knock-down of RPTPs resulted in a
conspicuous phenotype in a superficial dorsal nerve (Fig. 4A). In
control embryos, the untreated and treated nerves had three to
four major bundles, with substantial lateral branching. In em-
bryos treatedwith dsRNA targeting RPTPs, we saw changes in the
morphology of this nerve on the treated side. In some cases, there
were defasciculation errors such that the nerve had only one or
twomajor bundles, and limited subbranching. In other cases, the
nerve was much smaller, seeming to be delayed in its outgrowth,
or was missing entirely.
To quantify these effects, we characterized embryos as “af-
fected” (gross differences in the dorsal
nerve between treated and untreated
sides) or “unaffected” (only minor differ-
ences between the two sides) (seeMaterials
andMethods). Approximately 70%of em-
bryos treated with dsRNA targeting either
the PTP- or PTP- were categorized as
affected (Fig. 4B). Strikingly, 85% of
embryos treated with dsRNA targeting the
type III RPTP PTPRO were affected (Fig.
4B). These results suggest that the func-
tion of these RPTPs is essential for proper
guidance of the axons in this dorsal nerve.
We used several types of controls to de-
termine the specificity of these effects. As
controls for the experimental procedures,
we examined embryos in which the egg
was windowed but the embryowas left un-
touched, and embryos injected with PBS
and electroporated. We also used controls
to determine the specificity of the RNAi
itself. First, embryos were electroporated
with dsRNA targeting ChAT. ChAT is ex-
pressed in motor neurons at this time in
development but does not appear to be
necessary for initial axon outgrowth to
muscle targets (Misgeld et al., 2002). To
control for the possibility that interference
with any axon guidance cue would pro-
duce the phenotype we observed, we elec-
troporated embryos with dsRNA targeting
axonin-1. Axonin-1 is expressed in the ax-
ons of this dorsal nerve (Fig. 5A). The
dsRNA we used has been shown to knock
down axonin expression and to cause clear
and predictable defects in commissural
axon pathfinding (Pekarik et al., 2003). In
none of the control situations did we ob-
serve more than 20% affected embryos
(Figs. 4B, 5B). Indeed, RNAi for ChAT or
axonin-1 produced no increase in affected
embryos above that seen for PBS electro-
poration. Thus, knock-down of RPTPs
specifically affects axonal morphology in
this dorsal nerve.
To supplement our qualitative catego-
rizations of embryos, we used several
quantitative measures of phenotype. A
computer algorithm designed to delineate nerve from back-
ground (see Materials and Methods) counted pixels in images of
each nerve. This gave us an estimate of nerve area, which we used
to calculate a ratio of treated nerve area to untreated nerve area
(Fig. 6). In control embryos, the mean ratio was slightly larger
than 1; in PBS and ChAT embryos, the mean ratio was 0.9.
Embryos electroporated with dsRNA targeting PTP- or PTP-
had a ratio of 0.7. Remarkably, embryos electroporated with
dsRNA targeting PTPRO had nerves that were on average only
one-half as large as those of controls; this difference was highly
statistically significant. Similar results were obtained using the
Neurolucida program to calculate total nerve length from traced
images. Embryos treated with dsRNA targeting PTPRO had sig-
nificantly shorter treated nerves than ChAT control embryos
( p 0.001); PTP- and PTP- embryos also showed a decrease
Figure 4. Knock-down of RPTPs by in ovo RNAi in spinal cord affects the growth of a dorsal nerve in the limb. Spinal cordswere
electroporatedwith dsRNA targeting ChAT (n 16), Axonin-1 (Ax-1; n 16), PTP- (n 30), PTP- (n 27), or PTPRO (n
37) and allowed to develop for 2 d before fixation and fluorescent staining with anti-neurofilament. Control embryos (n 25)
were only windowed, and PBS embryos (n 19) were electroporated with PBS. A, Representative photomicrographs showing
dorsal views of whole-mount embryos treated with PBS (left 2 panels) or PTPRO dsRNA (right 2 panels). The left (treated) dorsal
nervewas visually comparedwith the right (untreated) dorsal nerve (arrowheads). Embryoswere categorized as unaffected (u) or
affected (a); affected embryos hadmuch smaller ormissing nerves (top), or showedmajor changes in fasciculation and branching
(bottom). Scale bar, 0.5 mm. B, Quantification of dorsal nerve effect. The percentage of affected embryos is shown for each
treatment group. Eighty to 100% of control embryos [control (Con), PBS, ChAT, Ax-1] fall into the unaffected category. However,
the majority of embryos treated with dsRNA targeting the RPTPs were affected. A two-sided Fisher’s exact test was used to
compare treatment groupswith ChAT. *Significantly different,p0.01. ***Significantly different,p0.001. Themost severely
affected phenotypes (missing or greatly truncated nerves) were never seen with untouched, PBS, ChAT, or axonin-1 embryos;
percentages of severely affected embryos were as follows: PTP-, 23%; PTP-, 26%; PTPRO, 49% (data not shown).
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in nerve length on the treated side butwere
not significantly different from control.
Analysis of nerve branching (number
of primary branches on control and
treated sides) demonstrated a significant
effect of knocking down each of the RPTPs
we tested. Embryos treated with dsRNA
targeting PTP- had an average of 3.2 
0.2 primary branches on the untreated
side, but only an average of 2.0  0.2 pri-
mary branches on the treated side ( p 
0.0001; Wilcoxon matched-pairs t test).
Embryos treated with dsRNA targeting
PTP- or with PTPRO had an average of
2.8  0.1 primary branches on the un-
treated sides compared with 2.1 0.2 and
2.0 0.2 primary branches on the treated
sides, respectively ( p  0.01 and p 
0.001). In contrast, control embryos
treated with dsRNA targeting ChAT had
an average of 2.9  0.2 primary branches
on both the untreated and treated side. Overall, our quantitative
description of the phenotype followed the same pattern as that of
our qualitative data; knock-down of each of the three RPTPs
changed the size and morphology of the treated nerve, although
interference with PTPRO had the greatest effect in our experi-
ments. These data suggest that type IIa and type III RPTPs are
involved in axon pathfinding by chick motor neurons. The effect
we sawwith PTPROknock-down represents the first evidence for
an in vivo role of a type III RPTP in vertebrate axon growth.
The affected dorsal nerve is the anterior iliotibialis
To identify the dorsal nerve affected by RPTP knock-down, we
followed the projection pattern of this nerve during development
by neurofilament staining of embryos at HH 29–32 (E6–E7.5)
(data not shown). Over time, the nerve spreads as a thin sheet
covering the lateral surface of the thigh. This pattern corresponds
to the position of the anterior iliotibialis, a thin, sheet-likemuscle
that contains both fast- and slow-twitch muscle fibers (Land-
messer, 1978a;Milner et al., 1998). To confirm this identification,
we used retrograde DiI labeling in E5.5 embryos to identify the
neurons of origin of the dorsal nerve. We found that the motor
portion of the nerve arises from neurons in the lateral portion of
the ventral horn in lumbosacral segments (LS) 1–3 (Fig. 7). This
is fully consistent with the position of the anterior iliotibialis
motor neuron pool (Landmesser, 1978a). Based on the position
and projection pattern of the dorsal nerve, and the position of the
motor neurons giving rise to this nerve, we will refer to it as the
AITIB. PTPROmRNA is found in, but is not limited to, neurons
of the E5 ventralmotor column inwhich the AITIBmotor pool is
found (Figs. 1, 7B) (data not shown). Thus, PTPRO appears to be
expressed in the motor neuron pool that gives rise to the AITIB
during the time of AITIB outgrowth. Sensory neurons were also
labeled by the retrograde tracing (Fig. 7B, inset), showing that the
affected AITIB is a mixed nerve.
To examine the effects of RNAi on individualmotor axons, we
performed anterograde DiI tracing. DiI was placed in the lateral
portion of the ventral horn in vibratome sections from LS 1–3 of
embryos electroporated with dsRNA targeting PTPRO, and trac-
ing was examined using a confocal microscope. Because of limi-
tations on the thickness of sections suitable for this type of mi-
croscopy, the entire length of the AITIB was rarely identified.
However, we consistently observed that labeled motor axons on
the treated side of the embryo (Fig. 8A) were shorter than those
on the untreated side of the embryo (B). We did not observe
differences in motor axon trajectories within the spinal cord or
the plexus region. Thus, these experiments indicate that AITIB
motor axon growth is retarded by knock-down of PTPRO.
Figure 5. Axonin-1 is expressed in the dorsal nerve, but knock-down does not affect outgrowth. A, Dorsal view of an embryo
stained with an antibody to axonin-1. The dorsal nerve is axonin-1 positive (arrow). B, Dorsal view of a representative embryo
electroporated with dsRNA targeting axonin-1 and stained with anti-neurofilament. The left (treated) nerve has an unaffected
phenotype.
Figure 6. Quantification of dorsal nerve phenotype. A, An Igor-based program (see Materi-
als andMethods) was used to calculate the number of pixels contained in the area of the dorsal
nerve. The program accurately identified the nerve fascicles; compare the immunostained im-
age (left) (scale bar, 0.5 mm) with the overlay generated by the nerve quantification program
(right).B, Nerve areas in electroporated embryos are presented as a ratio of left (treated) nerve
area to right [control (Con)] nerve area (mean SEM). Therewas a tendency for smaller nerves
in the embryos treatedwith PTP- or PTP- dsRNA; the PTPRO groupwas significantly smaller
than ChAT control embryos. **p 0.01.
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The AITIB phenotype is not caused by increased death of
motor neurons
If in ovoRNAi of RPTPs led to increasedmotor neurondeath, this
could contribute to a reduction in the size of the AITIB. To in-
vestigate this possibility, we counted the number of motor neu-
rons in embryos electroporated with PTPRO dsRNA. Serial sec-
tions from PTPRO or control embryos were stained with an
antibody to the transcription factor Isl-2, an early marker for
motor neurons (Tsuchida et al., 1994). Isl-2-positive cells were
counted using design-based stereology (see Materials and Meth-
ods) in treated and untreated sides of spinal cord lumbosacral
segments 1–5. Similar numbers of Isl-2-positive cells in individ-
ual sections were seen in both PTPRO RNAi embryos and in
controls (Fig. 9). Additionally, the estimates of total motor neu-
rons in the entire volume examinedwere similar between the two
sides of the embryos. The ratio of Isl-2-positive cells in treated
compared with untreated spinal cord halves was 0.98 0.02 for
control embryos, and 0.99  0.01 for PTPRO RNAi embryos
(n 3 for both groups). Thus, cell death of motor neurons does
not contribute substantially to the mean 50% decrease in AITIB
size in PTPRO-targeted embryos.
Combinatorial RNAi: evidence for competition between type
IIa and type III RPTPs
Experiments in Drosophila have shown that type IIa and type III
RPTPs can cooperate or compete in the guidance of both central
axon fascicles and peripheral motor axons (Desai et al., 1997; Q.
Sun et al., 2000; Schindelholz et al., 2001). Do vertebrate RPTPs
also interact in the regulation of motor axon pathfinding? To
answer this question, we used combinatorial RNAi. It has been
demonstrated that several genes can be silenced together by in-
jecting a combination of dsRNAs targeting the genes of interest, if
the RNAs are injected at reasonably high concentrations (Schmid
et al., 2002). For our experiments, we first determined that 500
ng/l was the dsRNA concentration that produced the most re-
liable PTPRO phenotype (data not shown). In the combination
experiments, we therefore used all of the dsRNAs at a final con-
centration of 500 ng/l.
Embryos in which both type IIa RPTPs (PTP- and PTP-)
were targeted had approximately the same severity of phenotypes
as embryos in which either PTP- or PTP- alone were targeted,
although the percentage affected was slightly higher in the com-
bination experiments than for either RPTP alone (Fig. 10A).
These data provide no evidence for a strong interaction between
PTP- and PTP- in the growth of the AITIB.
Embryos in which either PTP- or PTP- was targeted con-
comitantly with the type III RPTP, PTPRO, were on average less
severely affected than embryos in which PTPRO alone was tar-
geted (Fig. 10B). In the case of PTPRO/PTP-, only 50% of em-
bryos were classified as affected, compared with 87% for PTPRO
alone, a significant reduction ( p  0.01). To ensure that this
reduction in phenotype severity was not simply attributable to
addition of a second dsRNA, we used a combination of PTPRO
and ChAT dsRNAs. A slight and nonsignificant reduction in the
percentage of affected embryos was seen in this case, indicating
that the reduction in phenotype severity seen with PTPRO/
PTP- was specific to this combination. These data suggest that
PTPRO and PTP- compete functionally during the growth of
the AITIB nerve. A similar trendwas seen for PTP-/PTPRO, but
the data do not allow a conclusion in this case.
Finally, we tested a combination of dsRNAs targeting all three
RPTPs (Fig. 10C). In this case, the reversion of the PTPRO phe-
notype was even more dramatic, with only 41% of the embryos
categorized as affected ( p 0.01). As a control for the use of large
amounts of dsRNA, we tested PTPRO dsRNA in conjunction
with 1000 ng/l ChAT dsRNA; no significant difference was seen
compared with PTPRO alone. These data suggest that PTP-,
together with PTP-, counteracts the role of PTPRO in control-
ling the outgrowth of the AITIB. The need to balance the func-
tional activities of type IIa and type III RPTPs in motor axon
guidance is similar to the situation in Drosophila. The data may
indicate a conserved function for RPTPs in motor axon out-
growth from flies to vertebrates.
Discussion
RNAi targeting of PTP-, PTP-, or PTPRO in spinal motor
neurons led to dramatic changes in the morphology of the devel-
opingAITIB nerve. AlthoughRNAi produced similar changes for
all of the RPTPs examined, knock-down of the type III RPTP
PTPRO produced the strongest effects. Knock-down of the type
IIa RPTPs in combination with PTPRO suggests competition
among these RPTPs in axon guidance. Notably, our results pro-
vide the first evidence implicating a type III RPTP in vertebrate
axon pathfinding.
Figure 7. The trajectory and origin of the dorsal nerve confirm it as the AITIB nerve. A,
Retrograde DiI labeling from the dorsal nerve. Transverse section of the lumbar region of an
embryo. The arrow indicates the position of DiI-soaked nitrocellulose pledget placed in the
dorsal limb bud in the AITIB termination zone. DiI labels axons extending from neurons in the
ventrolateral spinal cord (arrowhead).B, Retrograde labeling from the dorsal nerve labels neu-
rons in the ventrolateral region of the lumbar enlargement. A single neuron is in focus; its axon
can be seen leaving the cord, and its dendrites extend some distance medially and laterally
(arrowhead). The position of labeled neurons is consistent with the location of the AITIB motor
neuronpool (Milner et al., 1998). Inset, In another section, bothmotor (arrowhead) and sensory
(arrow) neurons are labeled by the retrograde tracing. Scale bars, 100m.
Figure 8. Motor axons are shorter when electroporated with dsRNA targeting PTPRO. Con-
focal images of a 200m section of an embryo treated with PTPRO dsRNA. DiI was placed into
the lateral ventral horns of a section from LS 2. Anterograde tracing is apparent in the AITIB at a
greater distance from the ventral horn in the untreated side of the embryo (B) than in the
treated side (A). This was a consistent finding after PTPRO knock-down (n 6 embryos) and
was not seen with control injections (n 7 embryos). Arrowheads indicate the plexus region
where the AITIB turns to grow dorsally. Scale bar, 100m.
Stepanek et al. • RPTPs and Vertebrate Motor Axon Guidance J. Neurosci., April 13, 2005 • 25(15):3813–3823 • 3819
RPTPs could be acting at several places
to regulate outgrowth of AITIB axons.
Embryos lacking AITIB nerves suggest in-
volvement of RPTPs in axon initiation or
spinal nerve exiting. Alternatively, RPTPs
could function at choice points along ax-
onal pathways; loss of RPTP function
could cause axons to stall or make incor-
rect decisions. In Drosophila, loss-of-
function mutants of type IIa RPTPs ex-
hibit “stall” or “stop short” phenotypes in
motor axon fascicles (Desai et al., 1996;
Desai et al., 1997). As in these mutants,
phenotypes in our RPTP RNAi embryos
varied considerably.We cannot determine
whether this phenotypic variation is at-
tributable to incomplete “penetrance” or
variation in the efficacy of the RNAi, but
incomplete penetrance has been observed
in many cases for Drosophila RPTPs.
Retrograde tracing from the AITIB also
labeled sensory neurons. Thus, the af-
fected nerve contains sensory fibers. It is
unlikely that our electroporation targeted
sensory neurons, because we found trans-
fection of sensory ganglia only when we
electroporated before HH 18. Our pheno-
typic analysis suggests that thewhole nerve
is affected by RPTP dsRNA electropora-
tion, including the sensory component.
This finding is consistent with a body of
evidence linking sensory axon pathfinding
to decisions made by earlier-extending
motor axons (Honig et al., 1986; Land-
messer and Honig, 1986; Scott, 1986;
Wang and Scott, 1997; Honig et al., 1998).
The RPTP knock-down phenotypes
also included gross changes in fascicula-
tion pattern. Some embryos exhibited
phenotypes in which primary or second-
ary branches of the nerves appeared to be
fused together in the treated side. In some
cases, secondary and tertiary branches developedmore distally in
the treated AITIB than in the control AITIB. These phenotypes
implicate RPTPs, and particularly PTPRO, in defasciculation.
The Drosophila PTPRO relative DPTP10D is involved in defas-
ciculation of the intersegmental nerve b, along with other RPTPs
(Sun et al., 2001).
RPTPs likely act both as ligands and as receptors, and the
effects we observe may be attributable to loss of either or both
functions. Proper guidance of photoreceptor cell axons in Dro-
sophila, for example, is dependent on both cell-autonomous
(presumably receptor) functions of RPTPs, as well as non-cell-
autonomous (presumably ligand) functions (Garrity et al., 1999;
Clandinin et al., 2001; Maurel-Zaffran et al., 2001). Additionally,
RPTPs might act in cis to regulate other guidance molecule-
receptor interactions within the axon or on growth cones. The
Caenorhabditis elegans RPTP Clr-1, for example, inhibits signal-
ing in cis through the netrin receptorUNC40 (Chang et al., 2004).
In the spinal cord, effects of RNAi could be attributable to loss of
RPTPs as receptors on AITIB motor neurons, making the neu-
rons unresponsive to growth-promoting factors. Effects could
also be attributable to loss of RPTPs from other cells, so that
receptors on the AITIB are not activated by their growth-
promoting ligands. In the spinal nerves and crural plexus, RPTPs
could also be acting autonomously within the AITIB axons, or
could be signaling the AITIB axons from neighboring nerve fi-
bers. Once in the limb, changes in AITIB morphology would
presumably be attributable to cell-autonomous RPTP action.
Interpretation of these knock-down experiments is compli-
cated by our limited understanding of the binding partners of
RPTPs and their effects on RPTP function. PTP- binds ho-
mophilically (Wang andBixby, 1999), although itmay have other
partners. PTP- binds to heparan sulfate proteoglycans and to
other uncharacterized ligands in retinal basement membranes
(Ledig et al., 1999b; Aricescu et al., 2002). The binding partners of
PTPRO are unknown, although it is unlikely to bind homophili-
cally (Stepanek et al., 2001).
It is difficult to predict effects of RPTP knock-down onmotor
axon growth from available data. Because PTP- promotes neu-
rite outgrowth in vitro, and putative dominant-negative mutants
of PTP- cause decreased growth of retinotectal axons (Johnson
et al., 2001), one might expect the removal of PTP- to cause a
decrease in size of the nerve. Knock-down of PTP- indeed de-
Figure 9. dsRNA electroporation does not cause motor neuron cell death. Treated and control embryos were dissected at E5,
and sectionswere stainedwith Islet-2 antibody to identifymotor neurons of the lateralmotor column. LS 2 spinal cord sections of
untouched embryos (A) and dsPTPRO RNA-treated embryos (B) have the same gross morphology and have the same density of
cells immunopositive for Islet-2 (see insets). Scale bar, 100m.
Figure 10. Targeting of multiple RPTPs suggests complex interactions in axon growth. Embryos were treated with dsRNA
targeted to the indicated RPTPs. Embryos were examined as whole mounts and categorized as unaffected or affected. A, Simul-
taneous targeting of PTP- and PTP- (n 21) produced no significant change in the number of affected embryos compared
with PTP- or PTP- alone. B, Simultaneous targeting of PTP- and PTPRO (n 20) produced significantly fewer affected
embryos than PTPRO alone ( p 0.01; Fisher’s exact test). Simultaneous targeting of PTP- and PTPRO (n 20), or of ChAT and
PTPRO (n24), producedno significant change in thenumber of affected embryos comparedwithPTPROalone.C, Simultaneous
targeting of PTP-, PTP-, and PTPRO (n 22) reduced the percentage of affected embryos to less than one-half that seen by
targeting PTPRO alone ( p 0.001; Fisher’s exact test). Control experiments in which PTPRO was combined with a 2 concen-
tration of dsChAT RNA (n 21) produced no significant change in the number of affected embryos compared with PTPRO alone,
indicating that the effect of the RPTP knock-down is specific and not attributable to dilution of PTPRO dsRNA by other dsRNA.
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creased some aspects of AITIB growth. In contrast, available ev-
idence suggests that unliganded PTP- is inhibitory to axon
growth, and that ligand binding may promote growth by inacti-
vating PTP- (Ledig et al., 1999b; Johnson et al., 2001). Consis-
tent with this idea, loss of PTP- function accelerates regenera-
tion of adult peripheral nerves (McLean et al., 2002). In our
experiments, however, knock-down of PTP- alone did not ap-
pear to increase nerve growth. It is possible that PTP- has dis-
tinct functions in different axonal populations. Alternatively, li-
gand rather than receptor functions may be important. The
situation for PTPRO is even less clear. Although the extracellular
domain of PTPRO is neurite inhibitory in vitro (Stepanek et al.,
2001), effects of PTPRO as a receptor in PTPRO-expressing neu-
rons have not been studied.
Although the three RPTPs we tested appear to have distinct
activities in vitro, the gross phenotypes caused by single knock-
downs in motor neurons were similar. Because there is no exac-
erbation of the single-knock-down phenotypes in embryos
treated with dsRNA targeting PTP- and PTP-, these RPTPs
might have partially redundant functions in regulating the out-
growth of the AITIB. However, double- and triple-combination
experiments indicate a functional competition between PTPRO
and the type IIa RPTPs in AITIB growth. This unexpected com-
plexity is likely to be partially attributable to our level of analysis.
It is clear that functional interactions among RPTPs cannot be
reliably predicted on the basis of observations of gross pheno-
types of single null mutants (Krueger et al., 1996; Desai et al.,
1997; Schindelholz et al., 2001; Sun et al., 2001).
At what level are these RPTPs interacting to regulate axon
growth? There is no indication thus far that any RPTPs share the
same ligands or receptors, although LAR, PTP-, and PTP- do
share potential heparan sulfate proteoglycan bindingmotifs (Ari-
cescu et al., 2002; Johnson and Van Vactor, 2003). It seems more
likely that the RPTPs are interacting downstream of ligand–re-
ceptor interactions. Little is known about neuronal substrates for
these RPTPs. PTP-, PTP-, and LAR bind to the liprin protein
family, which is implicated in several aspects of synapse forma-
tion (Serra-Pages et al., 1995; Zhen and Jin, 1999; Kaufmann et
al., 2002; Wyszynski et al., 2002). Substrates for PTPRO may
include Trk receptors (Beltran et al., 2003), in addition to the
novel neural protein NPCD (neuronal pentraxin with chromo
domain) (Chen and Bixby, 2005a,b). More progress has been
made in the discovery of potential substrates for LAR; it can act
together with Abl to coordinate phosphorylation/dephosphory-
lation of the profilin-interacting protein Ena. Additionally, LAR
interactswith the guanine nucleotide exchange factor Trio, which
can activate Rho family GTPases to regulate actin filaments
(Bixby, 2001; Johnson and Van Vactor, 2003). A recent paper
shows that PTP- interacts with an actin-binding protein called
MIM in fibroblasts, suggesting that cytoskeletal interactions are
common to type IIa RPTPs (Gonzalez-Quevedo et al., 2005). The
type IIa and type III RPTPs could have opposing effects on the
same signaling pathway, or affect opposing signaling pathways, to
control cytoskeletal rearrangements in the growth cone.
It is surprising that the axon pathfinding defects we saw with
RPTP knock-down were confined to the AITIB. PTP-, PTP-,
and PTPRO are expressed in many ventrolateral neurons
throughout the length of the lumbosacral spinal cord. Based on
GFP transfection experiments, we produce efficient electropora-
tion in 7–10 segments of the cord, in bothmedial and lateral cells.
Thus, it does not seem likely that the dsRNA is selectively entering
the AITIB motor pool. Our PTPRO–GFP experiments do not
provide evidence for selective efficacy of RNAi in different cell
populations. Possible explanations for the apparent selectivity
include the following: (1) lower baseline levels of RPTP expres-
sion in AITIB neurons, (2) lack of neighboring axon bundles in
the AITIB pathway to provide guidance cues, and (3) the timing
of growth relative to knock-down—the AITIB emerges preco-
ciously compared with other nerves from the crural plexus. The
isolation of the AITIB from other nerves may also play another
role. Perhaps pathfinding is disrupted in other axon fascicles, but
cannot be observed against a background of normal axons with
the assessment techniques we used.
The accessibility of chick spinal motor neurons combined
with the ability to perform RNAi with long dsRNAs has allowed
us to perform direct loss-of-function experiments with several
RPTPs in developing projection neurons. The strongest path-
finding defects were seen by targeting the type III RPTP, PTPRO.
Our data also support the idea of competition and cooperation
between type IIa and type III RPTPs in regulating vertebrate axon
guidance, suggesting an evolutionary conservation of RPTP
function. Among the major challenges remaining is the identifi-
cation of extracellular and intracellular binding partners of these
RPTPs, providing insight into the mechanisms underlying RPTP
function in axonal pathfinding.
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